1093
HKSE:1093
CSPC Pharmaceutical Group Limited
- Stock
Last Close
6.13
02/05 08:08
Market Cap
72.52B
Beta: 0.81
Volume Today
39.92M
Avg: 40.02M
PE Ratio
11.19
PFCF: 689.21
Dividend Yield
4.35%
Payout:0%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.45B - | 1.48B 2.55% | 1.63B 9.67% | 2.08B 27.67% | 2.73B 31.49% | 2.79B 2.05% | 2.20B 21.13% | 2.17B 1.26% | 2.52B 15.98% | 3.16B 25.60% | |
average payables | 975.43M - | 964.28M 1.14% | 1.02B 6.22% | 1.19B 16.49% | 2.28B 91.35% | 2.35B 2.80% | 1.33B 43.15% | 1.43B 7.33% | 1.82B 26.83% | 2.69B 48.25% | |
average receivables | 1.30B - | 2.78B 113.16% | 2.93B 5.59% | 1.46B 50.28% | 9.37B - | ||||||
book value per share | 0.57 - | 0.64 13.25% | 0.79 22.62% | 1.09 38.42% | 1.25 14.50% | 1.54 23.20% | 1.87 20.97% | 2.17 16.37% | 2.53 16.56% | 3.08 21.52% | |
capex per share | -0.06 - | -0.06 6.92% | -0.09 51.34% | -0.09 6.10% | -0.18 108.13% | -0.18 2.10% | -0.13 25.72% | -0.15 11.54% | -0.23 55.31% | ||
capex to depreciation | -1.33 - | -1.37 2.95% | -2.02 47.03% | -1.70 15.65% | -3.32 94.88% | -3.07 7.48% | -1.95 36.49% | -2.03 4.23% | -2.60 27.87% | ||
capex to operating cash flow | -0.45 - | -0.37 18.04% | -0.41 10.18% | -0.37 8.79% | -0.56 50.68% | -0.56 0.37% | -0.23 58.30% | -0.38 62.12% | -0.36 5.87% | ||
capex to revenue | -0.07 - | -0.07 1.82% | -0.10 31.51% | -0.08 17.74% | -0.12 49.21% | -0.10 18.40% | -0.06 34.18% | -0.06 0.17% | -0.09 39.47% | ||
cash per share | 0.10 - | 0.17 63.93% | 0.25 49.10% | 0.47 85.00% | 0.55 17.87% | 0.50 9.73% | 0.74 47.64% | 0.90 21.98% | 1.16 29.72% | 1.21 4.30% | |
days of inventory on hand | 97.39 - | 107.57 10.46% | 116.43 8.24% | 173.10 48.67% | 177.50 2.54% | 149.47 15.79% | 108.57 27.37% | 134.49 23.87% | 107.43 20.12% | 123.09 14.58% | |
days payables outstanding | 65.25 - | 67.87 4.01% | 73.15 7.78% | 92.76 26.82% | 190.82 105.71% | 84.12 55.92% | 72.43 13.90% | 87.98 21.47% | 84.52 3.93% | 111.45 31.86% | |
days sales outstanding | 108.55 - | 112.79 3.90% | 96.08 14.81% | 116.23 - | |||||||
debt to assets | 0.10 - | 0.11 10.15% | 0.08 29.02% | 0.05 40.58% | 0.00 93.23% | 0.01 129.54% | 0.01 47.81% | 0.00 74.30% | 0.01 415.21% | 0.01 7.07% | |
debt to equity | 0.15 - | 0.17 10.34% | 0.11 32.74% | 0.06 42.79% | 0.00 92.72% | 0.01 116.61% | 0.01 39.61% | 0.00 74.48% | 0.02 433.06% | 0.02 6.35% | |
dividend yield | 0.01 - | 0.01 12.82% | 0.01 11.79% | 0.01 48.51% | 0.01 91.70% | 0.01 28.40% | 0.02 92.69% | 0.02 3.89% | 0.02 28.50% | ||
earnings yield | 0.03 - | 0.03 18.49% | 0.04 28.14% | 0.02 39.23% | 0.05 96.19% | 0.03 29.42% | 0.05 69.16% | 0.06 1.97% | 0.06 12.59% | 0.08 20.80% | |
enterprise value | 40.19B - | 46.15B 14.84% | 47.45B 2.80% | 96.33B 103.03% | 66.33B 31.14% | 111.79B 68.53% | 88.10B 21.20% | 92.06B 4.50% | 88.01B 4.40% | 73.74B 16.21% | |
enterprise value over ebitda | 22.14 - | 19.98 9.77% | 16.29 18.44% | 33.36 104.75% | 14.09 57.77% | 20.90 48.33% | 12.81 38.71% | 11.98 6.44% | 10.22 14.67% | 8.23 19.54% | |
ev to operating cash flow | 27.82 - | 24.49 11.97% | 18.17 25.81% | 35.06 92.95% | 17.06 51.35% | 29.54 73.22% | 13.07 55.76% | 19.85 51.89% | 11.54 41.88% | ||
ev to sales | 4.59 - | 4.84 5.45% | 4.28 11.44% | 7.46 74.03% | 3.59 51.82% | 5.06 40.82% | 3.53 30.17% | 3.30 6.47% | 2.84 13.89% | 2.12 25.41% | |
free cash flow per share | 0.07 - | 0.10 49.73% | 0.14 29.18% | 0.15 9.16% | 0.14 3.14% | 0.14 2.92% | 0.43 210.80% | 0.24 44.25% | 0.41 70.92% | ||
free cash flow yield | 0.02 - | 0.03 29.06% | 0.03 23.78% | 0.02 44.91% | 0.02 40.44% | 0.01 40.93% | 0.05 278.44% | 0.03 47.67% | 0.05 76.54% | ||
graham net net | 0.03 - | 0.08 152.42% | 0.16 95.85% | 0.13 17.72% | 0.04 71.08% | 0.04 8.04% | 0.23 549.05% | 0.34 47.10% | 0.42 24.27% | 1.01 140.65% | |
graham number | 1.07 - | 1.34 24.77% | 1.71 28.05% | 2.21 29.11% | 2.75 24.47% | 3.29 19.54% | 4.26 29.64% | 4.79 12.44% | 5.40 12.72% | 6.15 14.00% | |
income quality | 1.11 - | 1.07 4.35% | 1.11 3.85% | 0.95 14.25% | 0.98 3.67% | 0.82 16.85% | 1.05 28.93% | 0.68 35.79% | 1.01 48.55% | ||
intangibles to total assets | 0.02 - | 0.02 15.85% | 0.01 19.13% | 0.01 19.33% | 0.04 299.20% | 0.05 20.76% | 0.02 56.48% | 0.02 18.82% | 0.05 188.50% | 0.01 90.11% | |
interest coverage | 30.54 - | 38.24 25.21% | 63.88 67.08% | 129.76 103.13% | 52.71 59.38% | 141.87 169.14% | 496.26 249.80% | 889.53 79.25% | 303.69 65.86% | 270.22 11.02% | |
interest debt per share | 0.09 - | 0.11 24.25% | 0.09 17.68% | 0.07 21.54% | 0.01 83.02% | 0.02 49.65% | 0.03 49.55% | 0.01 69.08% | 0.05 499.05% | 0.06 13.87% | |
inventory turnover | 3.75 - | 3.39 9.47% | 3.13 7.61% | 2.11 32.74% | 2.06 2.48% | 2.44 18.75% | 3.36 37.68% | 2.71 19.27% | 3.40 25.19% | 2.97 12.72% | |
invested capital | 0.15 - | 0.17 10.34% | 0.11 32.74% | 0.06 42.79% | 0.00 92.72% | 0.01 116.61% | 0.01 39.61% | 0.00 74.48% | 0.02 433.06% | 0.02 6.35% | |
market cap | 40.38B - | 46.85B 16.03% | 49.32B 5.27% | 99.88B 102.50% | 70.59B 29.33% | 115.72B 63.94% | 95.04B 17.87% | 101.25B 6.53% | 97.72B 3.48% | 86.19B 11.80% | |
net current asset value | 1.80B - | 2.45B 35.55% | 3.46B 41.29% | 6.27B 81.37% | 6.10B 2.59% | 6.90B 12.99% | 8.95B 29.80% | 12.42B 38.77% | 13.83B 11.32% | 17.04B 23.25% | |
net debt to ebitda | -0.11 - | -0.30 183.76% | -0.64 112.62% | -1.23 90.83% | -0.90 26.51% | -0.73 18.72% | -1.01 37.37% | -1.20 18.51% | -1.13 5.63% | -1.39 23.06% | |
net income per share | 0.09 - | 0.12 37.46% | 0.16 33.73% | 0.20 20.42% | 0.27 35.31% | 0.31 15.99% | 0.43 38.93% | 0.47 8.64% | 0.51 9.01% | 0.55 6.95% | |
operating cash flow per share | 0.13 - | 0.17 30.45% | 0.23 37.36% | 0.23 2.96% | 0.32 38.13% | 0.32 2.46% | 0.56 78.12% | 0.39 31.20% | 0.64 65.00% | ||
payables turnover | 5.59 - | 5.38 3.86% | 4.99 7.22% | 3.93 21.15% | 1.91 51.39% | 4.34 126.85% | 5.04 16.14% | 4.15 17.68% | 4.32 4.09% | 3.28 24.16% | |
receivables turnover | 3.36 - | 3.24 3.76% | 3.80 17.39% | 3.14 - | |||||||
research and ddevelopement to revenue | 0.08 - | 0.09 20.21% | 0.12 28.02% | 0.12 6.32% | 0.13 4.61% | 0.15 19.19% | |||||
return on tangible assets | 0.10 - | 0.13 20.81% | 0.14 14.73% | 0.13 9.87% | 0.15 13.57% | 0.15 0.68% | 0.18 18.05% | 0.16 6.37% | 0.15 6.42% | 0.13 16.72% | |
revenue per share | 0.77 - | 0.84 8.90% | 0.97 15.08% | 1.10 14.15% | 1.54 39.49% | 1.85 19.98% | 2.09 12.85% | 2.33 11.74% | 2.60 11.35% | 2.93 12.76% | |
roe | 0.16 - | 0.19 21.38% | 0.21 9.06% | 0.18 13.01% | 0.21 18.18% | 0.20 5.85% | 0.23 14.84% | 0.22 6.64% | 0.20 6.48% | 0.18 11.99% | |
roic | 0.14 - | 0.17 18.84% | 0.19 13.15% | 0.17 10.53% | 0.22 27.36% | 0.20 8.86% | 0.22 10.07% | 0.22 0.38% | 0.20 7.91% | 0.17 14.45% | |
sales general and administrative to revenue | 0.05 - | 0.05 6.78% | 0.04 4.65% | 0.04 - | 0.03 8.69% | 0.04 11.97% | 0.04 4.43% | 0.04 4.62% | |||
shareholders equity per share | 0.57 - | 0.64 13.25% | 0.79 22.62% | 1.09 38.42% | 1.25 14.50% | 1.54 23.20% | 1.87 20.97% | 2.17 16.37% | 2.53 16.56% | 3.08 21.52% | |
stock based compensation to revenue | 0.00 - | 0.00 - | 0.00 20.33% | 0.00 73.91% | 0.01 716.47% | ||||||
tangible asset value | 6.27B - | 7.14B 13.80% | 8.95B 25.47% | 12.69B 41.68% | 14.08B 10.96% | 18.19B 29.25% | 22.44B 23.35% | 26.21B 16.79% | 29.50B 12.55% | 38.30B 29.82% | |
tangible book value per share | 0.55 - | 0.63 13.78% | 0.78 24.38% | 1.08 38.63% | 1.17 8.28% | 1.52 29.57% | 1.88 23.36% | 2.19 16.80% | 2.48 12.89% | 3.23 30.32% | |
working capital | 2.40B - | 3.49B 45.17% | 3.89B 11.54% | 6.58B 69.21% | 6.54B 0.56% | 7.46B 14.01% | 9.62B 28.94% | 13.11B 36.29% | 15.00B 14.41% | 18.24B 21.58% |
All numbers in HKD (except ratios and percentages)